Graciela Pavon-Djavid

Dr. Graciela Pavon-Djavid

Institut Galilée, université Sorbonne Paris Nord, Villetaneuse, France
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
MRMarc Robin
Marc Robin
EMElodie Mouloungui
Elodie Mouloungui
GDGabriel Castillo Dali
Gabriel Castillo Dali
YWYan Wang
Yan Wang
JSJean-Louis Saffar
Jean-Louis Saffar
NNNadine Nassif
Nadine Nassif
Autologous bone (AB) is the gold standard for bone-replacement surgeries1, despite its limited availability and the need for an extra surgical site. Traditionally, competitive biomaterials for bone repair have focused on mimicking the mineral aspect of bone, as evidenced by the widespread clinical use of bioactive ceramics2. However, AB also exhibits hierarchical organic structures that might substantially affect bone regeneration. Here, using a range of cell-free biomimetic-collagen-based materials in murine and ovine bone-defect models, we demonstrate that a hierarchical hybrid microstructure—specifically, the twisted plywood pattern of collagen and its association with poorly crystallized bioapatite—favourably influences bone regeneration. Our study shows that the most structurally biomimetic material has the potential to stimulate bone growth, highlighting the pivotal role of physicochemical properties in supporting bone formation and offering promising prospects as a competitive bone-graft material.

7 May 2015 in Marine Drugs
Verified
Journal Article
Open access
PDF file
PRPhilippe Régnier
Philippe Régnier
JBJorge Bastias
Jorge Bastias
Violeta Rodriguez-RuizVioleta Rodriguez-Ruiz
Violeta Rodriguez-Ruiz
NCNoelia Caballero-Casero
Noelia Caballero-Casero
CCCarmen Caballo
Carmen Caballo
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid
Astaxanthin, a powerful antioxidant, is a good candidate for the prevention of intracellular oxidative stress. The aim of the study was to compare the antioxidant activity of astaxanthin present in two natural extracts from Haematococcus pluvialis, a microalgae strain, with that of synthetic astaxanthin. Natural extracts were obtained either by solvent or supercritical extraction methods. UV, HPLC-DAD and (HPLC-(atmospheric pressure chemical ionization (APCI)+)/ion trap-MS) characterizations of both natural extracts showed similar compositions of carotenoids, but different percentages in free astaxanthin and its ester derivatives. The Trolox equivalent antioxidant capacity (TEAC) assay showed that natural extracts containing esters displayed stronger antioxidant activities than free astaxanthin. Their antioxidant capacities to inhibit intracellular oxidative stress were then evaluated on HUVEC cells. The intracellular antioxidant activity in natural extracts was approximately 90-times higher than synthetic astaxanthin (5 µM). No modification, neither in the morphology nor in the viability, of vascular human cells was observed by in vitro biocompatibility study up to 10 µM astaxanthin concentrations. Therefore, these results revealed the therapeutic potential of the natural extracts in vascular human cell protection against oxidative stress without toxicity, which could be exploited in prevention and/or treatment of cardiovascular diseases.

9 July 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
RLRebecca Landon
Rebecca Landon
VGVirginie Gueguen
Virginie Gueguen
Hervé PetiteHervé Petite
Hervé Petite
Didier LetourneurDidier Letourneur
Didier Letourneur
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid
FAFani Anagnostou
Fani Anagnostou
Oxidative stress (OS) plays a pivotal role in diabetes mellitus (DM) onset, progression, and chronic complications. Hyperglycemia-induced reactive oxygen species (ROS) have been shown to reduce insulin secretion from pancreatic β-cells, to impair insulin sensitivity and signaling in insulin-responsive tissues, and to alter endothelial cells function in both type 1 and type 2 DM. As a powerful antioxidant without side effects, astaxanthin (ASX), a xanthophyll carotenoid, has been suggested to contribute to the prevention and treatment of DM-associated pathologies. ASX reduces inflammation, OS, and apoptosis by regulating different OS pathways though the exact mechanism remains elusive. Based on several studies conducted on type 1 and type 2 DM animal models, orally or parenterally administrated ASX improves insulin resistance and insulin secretion; reduces hyperglycemia; and exerts protective effects against retinopathy, nephropathy, and neuropathy. However, more experimental support is needed to define conditions for its use. Moreover, its efficacy in diabetic patients is poorly explored. In the present review, we aimed to identify the up-to-date biological effects and underlying mechanisms of ASX on the ROS-induced DM-associated metabolic disorders and subsequent complications. The development of an in-depth research to better understand the biological mechanisms involved and to identify the most effective ASX dosage and route of administration is deemed necessary.

1 January 2018 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
MZMarisol Zuluaga
Marisol Zuluaga
VGVirginie Gueguen
Virginie Gueguen
Didier LetourneurDidier Letourneur
Didier Letourneur
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid

22 November 2010 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
SSShalini Saxena
Shalini Saxena
ARAlok R. Ray
Alok R. Ray
AKArti Kapil
Arti Kapil
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid
Didier LetourneurDidier Letourneur
Didier Letourneur
AMAnne Meddahi‐Pellé
Anne Meddahi‐Pellé

1 January 2021 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
APAli Pourali
Ali Pourali
MRMohammad Reza Rashidi
Mohammad Reza Rashidi
JBJaleh Barar
Jaleh Barar
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid
YOYadollah Omidi
Yadollah Omidi